Results 161 to 170 of about 3,904 (202)
Some of the next articles are maybe not open access.

Elevated Plasma Calcifediol Is Associated With Aggressive Periodontitis

Journal of Periodontology, 2009
Background: Vitamin D is associated with a number of inflammatory diseases and plays a significant role in regulating bone metabolism. Serum calcifediol was demonstrated to be potentially associated with periodontal disease. The purpose of this study was to evaluate whether an association exists between plasma calcifediol concentrations and aggressive ...
Kaining Liu   +2 more
exaly   +3 more sources

The Efficacy of Calcifediol in Renal Osteodystrophy

Archives of Internal Medicine, 1978
Bone disease continues to be a problem for patients who are undergoing long-term hemodialysis.1-4Although the clinical syndrome of renal osteodystrophy varies from center to center and from patient to patient, it is generally believed that disturbances in vitamin D metabolism are almost always present and play a pivotal role in its pathogenesis.
R, Recker   +5 more
openaire   +3 more sources

Development of Highly Sensitive and Specific and Genetically Encoded Biosensors for Calcifediol and Calcitriol Detection.

ACS Sensors
1α,25-Dihydroxyvitamin D3 (calcitriol) and 25-hydroxyvitamin D3 (calcifediol) are essential steroid metabolites that serve as key indicators of vitamin D3 status in the human body.
Kang Ma   +6 more
semanticscholar   +1 more source

#1748 Single-dose pharmacokinetics of extended-release calcifediol in healthy Japanese and non-Japanese volunteers

Nephrology, Dialysis and Transplantation
ERC is currently approved in the United States and certain European countries at a daily dose of 30 mcg, escalating as needed to 60 mcg, for the treatment of secondary hyperparathyroidism (SHPT) in patients with non-dialysis chronic kidney disease (
Charles W. Bishop, Akhtar Ashfaq
semanticscholar   +1 more source

Complete resolution of calciphylaxis in a renal transplant patient with Calcifediol

Postgraduate Medical Journal, 2021
Presentation: A 62-year-old woman with a Living Donor Kidney transplant in 2008 complicated with chronic kidney disease III, lupus nephritis, hypothyroidism (but no history of diabetes) presented with painful, bilateral, medial calf ischaemic ulcerations (figure 1), which on punch biopsy revealed calciphylaxis (figure 2).
Mohankumar Doraiswamy   +3 more
openaire   +2 more sources

Effect of Race, Gender and Age on Intrinsic Diurnal Variation of Serum Calcifediol.

Journal of Steroid Biochemistry and Molecular Biology
Intrinsic diurnal variation of serum calcifediol (25-hydroxyvitamin D3) was evaluated in healthy United States (US) adults by race, gender and age. Eligible participants (18-55 years old, body mass index 18-30kg/m2, body weight ≥50kg) were enrolled with ...
Charles W. Bishop   +4 more
semanticscholar   +1 more source

Calcifediol in Chronic Renal Insufficiency

JAMA: The Journal of the American Medical Association, 1976
To the Editor.— The reader who is not highly familiar with the recent developments concerning vitamin D and its various active forms may be misled by certain comments made (235: 164, 1976) by Teitelbaum and associates. First, the major reason for the interest in the treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol (1,25-dihydroxy ...
openaire   +2 more sources

Vitamin D supplementation: cholecalciferol, calcifediol, and calcitriol

European Journal of Clinical Nutrition, 2020
The specific compound that is meant for use in the context of vitamin D supplementation is often ambiguous. The term "supplementation" has been used in the context of cholecalciferol, ergocalciferol, calcidiol, and calcitriol. In nature, by far the major form of vitamin D that nurtures the body is cholecalciferol.
openaire   +2 more sources

Calcifediol

Reactions Weekly, 2022
openaire   +2 more sources

Calcifediol

Reactions Weekly, 2021
openaire   +2 more sources

Home - About - Disclaimer - Privacy